Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Illumina Laboratory Services, |
RCV000613613 | SCV000444335 | uncertain significance | Autosomal recessive spinocerebellar ataxia 10 | 2018-01-12 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. |
Ce |
RCV000415975 | SCV000493216 | likely benign | not provided | 2024-11-01 | criteria provided, single submitter | clinical testing | ANO10: BS2 |
Gene |
RCV000415975 | SCV000529825 | uncertain significance | not provided | 2016-07-13 | criteria provided, single submitter | clinical testing | The Y327C variant in the ANO10 gene has not been reported previously as a pathogenic variant, nor as a benign variant, to our knowledge. Although not present in the homozygous state, the NHLBI ESP Exome Sequencing Project reports Y327C was observed in 60/8600 (0.7%) alleles from individuals of European American background, indicating it may be a rare variant in this population. The Y327C variant is a non-conservative amino acid substitution, which occurs at a position that is conserved across species. However, in silico analysis is inconsistent in its predictions as to whether or not the variant is damaging to the protein structure/function. We interpret Y327C as a variant of uncertain significance. |
Athena Diagnostics | RCV000415975 | SCV000612354 | likely benign | not provided | 2020-06-15 | criteria provided, single submitter | clinical testing | |
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000613613 | SCV000744191 | likely benign | Autosomal recessive spinocerebellar ataxia 10 | 2016-09-29 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000415975 | SCV001110581 | likely benign | not provided | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002520121 | SCV003594368 | uncertain significance | Inborn genetic diseases | 2021-06-11 | criteria provided, single submitter | clinical testing | The c.980A>G (p.Y327C) alteration is located in exon 6 (coding exon 5) of the ANO10 gene. This alteration results from a A to G substitution at nucleotide position 980, causing the tyrosine (Y) at amino acid position 327 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Mayo Clinic Laboratories, |
RCV000415975 | SCV004226097 | uncertain significance | not provided | 2023-02-03 | criteria provided, single submitter | clinical testing | BS1 |
Diagnostic Laboratory, |
RCV000613613 | SCV000734281 | likely benign | Autosomal recessive spinocerebellar ataxia 10 | no assertion criteria provided | clinical testing |